FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAug 22, 2024 — The updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID...
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives …
WEBAug 23, 2021 — COMIRNATY is the first COVID-19 vaccine to be granted FDA approval ; Approval is based on a comprehensive submission package including six-month efficacy and safety data after second dose; More than 1.2 billion Pfizer-BioNTech doses have been delivered to more than 120 countries or territories around the world since December 2020
Pfizer’s updated COVID-19 vaccine approved by Health Canada
WEB19 hours ago — The mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 Omicron subvariant.
Health Canada approves updated Pfizer COVID-19 vaccine - CTV News
WEB19 hours ago — The mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 Omicron subvariant. Top health headlines, all in one place
Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 …
WEBSep 11, 2023 — Pfizer and BioNTech have submitted data for their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine to other regulatory authorities around the world. The COVID-19 vaccines (COMIRNATY®) by Pfizer and BioNTech are based on BioNTech’s proprietary mRNA technology and were developed by both companies.
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization …
WEBAug 22, 2024 — This release contains forward-looking information about Pfizer’s efforts to combat COVID-19, the collaboration between BioNTech and Pfizer to develop a COVID-19 vaccine, the BNT162b2 mRNA vaccine program, and the Pfizer-BioNTech COVID-19 Vaccine, also known as COMIRNATY ® (COVID-19 Vaccine, mRNA) (BNT162b2) including an approval in the U.S ...
FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better …
WEBSep 11, 2023 — Approval of Comirnaty (COVID-19 Vaccine, mRNA) to include the 2023-2024 formula, and a change to a single dose for individuals 12 years of age and older.
FDA Approves First COVID-19 Vaccine
WEBThe vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years...
Pfizer Canada and BioNTech Receive Health Canada Approval of …
WEB20 hours ago — Omicron KP.2 variant adapted vaccine COMIRNATY is now authorized in Canada for individuals 6 months of age and older. It is expected to be available in Canada in the coming weeks. The updated ...
PFE & BNTX Get Positive CHMP Opinion for Updated COVID-19 Jab
WEB1 day ago — The 2024 revenue guidance includes $8.5 billion in potential combined revenues for Paxlovid and Comirnaty, significantly lower than the combined revenues of $12.5 billion for 2023.
Skip to content